Robert Wasserman
Stock Analyst at Benchmark
(2.16)
# 2,647
Out of 4,832 analysts
120
Total ratings
40.38%
Success rate
-5.58%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OABI OmniAb | Reiterates: Buy | $6 | $1.52 | +294.74% | 9 | May 12, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $75 | $47.86 | +56.71% | 6 | May 8, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $119.55 | +17.11% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $26.74 | +30.89% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $0.50 | +503.62% | 6 | Apr 1, 2025 | |
| KMDA Kamada | Initiates: Buy | $15 | $7.06 | +112.46% | 1 | Mar 21, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $2.05 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $47.91 | +56.54% | 8 | Feb 20, 2025 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $135 | $105.09 | +28.46% | 10 | Dec 23, 2024 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $22.04 | +36.12% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $8 | $1.06 | +658.29% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.06 | +142.72% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $5.64 | +112.77% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.47 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $128.04 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.48 | +2,394.28% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $40.59 | +10.86% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $4.10 | -2.44% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.23 | +1,631.60% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.66 | +4,418.07% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $187.82 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $406.05 | +42.84% | 1 | Jul 16, 2021 |
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $1.52
Upside: +294.74%
Bio-Techne
May 8, 2025
Maintains: Buy
Price Target: $95 → $75
Current: $47.86
Upside: +56.71%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $119.55
Upside: +17.11%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $26.74
Upside: +30.89%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $0.50
Upside: +503.62%
Kamada
Mar 21, 2025
Initiates: Buy
Price Target: $15
Current: $7.06
Upside: +112.46%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.05
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $47.91
Upside: +56.54%
Ligand Pharmaceuticals
Dec 23, 2024
Reiterates: Buy
Price Target: $135
Current: $105.09
Upside: +28.46%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $22.04
Upside: +36.12%
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.06
Upside: +658.29%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.06
Upside: +142.72%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $5.64
Upside: +112.77%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.47
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $128.04
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.48
Upside: +2,394.28%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $40.59
Upside: +10.86%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $4.10
Upside: -2.44%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.23
Upside: +1,631.60%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.66
Upside: +4,418.07%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $187.82
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $406.05
Upside: +42.84%